HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vladimír Dolezal Selected Research

rapacuronium (Raplon)

12/2009Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vladimír Dolezal Research Topics

Disease

3Alzheimer Disease (Alzheimer's Disease)
03/2009 - 04/2003
2Neurodegenerative Diseases (Neurodegenerative Disease)
08/2009 - 01/2006
1Amyloid Plaque
04/2010
1Bronchial Spasm
12/2009
1Glioma (Gliomas)
08/2009
1Neuroblastoma
08/2009

Drug/Important Bio-Agent (IBA)

2Cholinergic Agents (Cholinergics)IBA
04/2010 - 08/2009
2Choline (Choline Chloride)IBA
08/2009 - 11/2005
2Proteins (Proteins, Gene)FDA Link
08/2009 - 04/2003
1rapacuronium (Raplon)FDA Link
12/2009
1Neuromuscular Blocking AgentsIBA
12/2009
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
12/2009
1Acetylcholine (Acetylcholine Chloride)FDA Link
08/2009
1choline transporterIBA
08/2009
1CholesterolIBA
03/2009
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2006
1Peptides (Polypeptides)IBA
04/2003
1Amyloid (Amyloid Fibrils)IBA
04/2003